Publication: Functional mapping of androgen receptor enhancer activity
dc.contributor.coauthor | Huang, Flora Chia-Chi | |
dc.contributor.coauthor | Morova, Tunç | |
dc.contributor.coauthor | Hu, Eugene | |
dc.contributor.coauthor | Yu, Lok Pak Ivan | |
dc.contributor.coauthor | Linder, Simon | |
dc.contributor.coauthor | Hoogstraat, M. | |
dc.contributor.coauthor | Stelloo, Suzan | |
dc.contributor.coauthor | Sar, Funda | |
dc.contributor.coauthor | Van der Poel, Henk | |
dc.contributor.coauthor | Saffarzadeh, Mohammadali | |
dc.contributor.coauthor | Le Bihan, Stephane | |
dc.contributor.coauthor | McConegy, Brian | |
dc.contributor.coauthor | Y Feng, Felix | |
dc.contributor.coauthor | Gleave, E. Martin | |
dc.contributor.coauthor | Bergman, M. Andries | |
dc.contributor.coauthor | Collins, Colin | |
dc.contributor.coauthor | Hach, Faraz | |
dc.contributor.coauthor | Zwart, Wilbert | |
dc.contributor.coauthor | Emberly, Eldon | |
dc.contributor.department | N/A | |
dc.contributor.department | Department of Molecular Biology and Genetics | |
dc.contributor.kuauthor | Özturan, Doğancan | |
dc.contributor.kuauthor | Altıntaş, Umut Berkay | |
dc.contributor.kuauthor | Gökbayrak, Bengül | |
dc.contributor.kuauthor | Lack, Nathan Alan | |
dc.contributor.kuprofile | PhD Student | |
dc.contributor.kuprofile | Faculty Member | |
dc.contributor.other | Department of Molecular Biology and Genetics | |
dc.contributor.researchcenter | Koç University Research Center for Translational Medicine (KUTTAM) / Koç Üniversitesi Translasyonel Tıp Araştırma Merkezi (KUTTAM) | |
dc.contributor.schoolcollegeinstitute | Graduate School of Health Sciences | |
dc.contributor.schoolcollegeinstitute | Graduate School of Sciences and Engineering | |
dc.contributor.yokid | N/A | |
dc.contributor.yokid | N/A | |
dc.contributor.yokid | N/A | |
dc.contributor.yokid | 120842 | |
dc.date.accessioned | 2024-11-09T12:14:27Z | |
dc.date.issued | 2021 | |
dc.description.abstract | Background: androgen receptor (AR) is critical to the initiation, growth, and progression of prostate cancer. Once activated, the AR binds to cis-regulatory enhancer elements on DNA that drive gene expression. Yet, there are 10-100x more binding sites than differentially expressed genes. It is unclear how or if these excess binding sites impact gene transcription. Results: to characterize the regulatory logic of AR-mediated transcription, we generated a locus-specific map of enhancer activity by functionally testing all common clinical AR binding sites with Self-Transcribing Active Regulatory Regions sequencing (STARRseq). Only 7% of AR binding sites displayed androgen-dependent enhancer activity. Instead, the vast majority of AR binding sites were either inactive or constitutively active enhancers. These annotations strongly correlated with enhancer-associated features of both in vitro cell lines and clinical prostate cancer samples. Evaluating the effect of each enhancer class on transcription, we found that AR-regulated enhancers frequently interact with promoters and form central chromosomal loops that are required for transcription. Somatic mutations of these critical AR-regulated enhancers often impact enhancer activity. Conclusions: using a functional map of AR enhancer activity, we demonstrated that AR-regulated enhancers act as a regulatory hub that increases interactions with other AR binding sites and gene promoters. | |
dc.description.fulltext | YES | |
dc.description.indexedby | WoS | |
dc.description.indexedby | Scopus | |
dc.description.indexedby | PubMed | |
dc.description.issue | 1 | |
dc.description.openaccess | YES | |
dc.description.publisherscope | International | |
dc.description.sponsoredbyTubitakEu | TÜBİTAK | |
dc.description.sponsorship | KWF Dutch Cancer Society | |
dc.description.sponsorship | Scientific and Technological Research Council of Turkey (TÜBİTAK) | |
dc.description.sponsorship | 1001 Projects | |
dc.description.sponsorship | NSERC | |
dc.description.sponsorship | Prostate Cancer Foundation BC | |
dc.description.sponsorship | Astellas Pharma Inc. | |
dc.description.version | Publisher version | |
dc.description.volume | 22 | |
dc.format | ||
dc.identifier.doi | 10.1186/s13059-021-02339-6 | |
dc.identifier.embargo | NO | |
dc.identifier.filenameinventoryno | IR02933 | |
dc.identifier.issn | 1474-760X | |
dc.identifier.link | https://doi.org/10.1186/s13059-021-02339-6 | |
dc.identifier.quartile | Q1 | |
dc.identifier.scopus | 2-s2.0-85105685636 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14288/1292 | |
dc.identifier.wos | 656231800004 | |
dc.keywords | Prostate cancer | |
dc.keywords | Androgen receptor | |
dc.keywords | Enhancers | |
dc.keywords | STARRseq | |
dc.keywords | Non-coding mutations | |
dc.language | English | |
dc.publisher | BioMed Central | |
dc.relation.grantno | 10084 ALPE | |
dc.relation.grantno | 119Z279 | |
dc.relation.uri | http://cdm21054.contentdm.oclc.org/cdm/ref/collection/IR/id/9573 | |
dc.source | Genome Biology | |
dc.subject | Biotechnology and applied microbiology | |
dc.subject | Genetics and heredity | |
dc.title | Functional mapping of androgen receptor enhancer activity | |
dc.type | Journal Article | |
dspace.entity.type | Publication | |
local.contributor.authorid | N/A | |
local.contributor.authorid | N/A | |
local.contributor.authorid | N/A | |
local.contributor.authorid | 0000-0001-7399-5844 | |
local.contributor.kuauthor | Özturan, Doğancan | |
local.contributor.kuauthor | Altıntaş, Umut Berkay | |
local.contributor.kuauthor | Gökbayrak, Bengül | |
local.contributor.kuauthor | Lack, Nathan Alan | |
relation.isOrgUnitOfPublication | aee2d329-aabe-4b58-ba67-09dbf8575547 | |
relation.isOrgUnitOfPublication.latestForDiscovery | aee2d329-aabe-4b58-ba67-09dbf8575547 |
Files
Original bundle
1 - 1 of 1